AI Future of Sacroiliitis Assessment
Dr. Rachel Tate speaks with Dr. Fabian Proft about Abstract 0383 at ACR22 Convergence.
Can I stop Methotrexate in RA?
Dr. Janet Pope and Dr. Charis Meng discuss Abstract 0916 at ACR22 Convergence.
Abstract 0916: Should RA Patients with Controlled Disease Taper Methotrexate from Targeted Therapy or Continue It? Risk Differences in Sustaining Remission from a Systematic Review and Meta-analysis
CAR-T Therapies in Antiphospholipid Antibody Syndrome
Dr. Michael Putman and Dr. Maximilian Konig discuss abstract 1677 at ACR22 Convergence.
Abstract 1677: Chimeric Autoantigen-T Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells
Copays Reduce Adherence to SLE Medications
Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA.
Copays Reduce Adherence to SLE Medications
Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA.
Does Race play a role in Mycophenolate Response in Scleroderma?
Dr. Eric Dein speaks with Dr. Lauren Smith about abstract 0521 at ACR22 Convergence in Philadelphia, PA.
Abstract 0521: Examination of Differential Response to Treatment with Mycophenolate Mofetil in Black and White Patients with Systemic Sclerosis
Fertility issues in SpA
Dr. Sheila Reyes speaks with Dr. Sabrina Hamroun about abstract 1673 at ACR22 Convergence.
Abstract 1673: Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort
Opioid use in PsA and SpA
Dr. Eric Dein discusses Abstract 1012 at ACR22 Convergence
PsA and SPA: Cyclers, Switchers, Who is the Winner?
Dr. Aurelie Najm discusses abstracts 1499 and 1600 at ACR22 Convergence in Philadelphia, PA.
Remibrutinib in Sjogren's Syndrome
Dr. Michael Putman reports on abstract 1113 presented at ACR22 Convergence meeting in Philadelphia, PA.
Abstract 1113: Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Study
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Is Cannabis Safe? (6.7.2024)
ACR’s Run at Goliath (PCPs) (5.31.2024)
The Window of Opportunity (5.24.2024)
Don't You Know Who I am (5.17.2024)
My Cancelled Lecture (5.11.2024)
Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs
Featured BSR Abstracts (5.3.2024)
SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush
Tuesday Night Rheumatology- Mastering SLE
Current & Future Biomarkers in SLE - Dr. Andrea Fava
Rheum Chapter Notes (4.26.2024)
Spondyloarthritis Faculty Panel Q&A - featuring Drs. Eric Ruderman, Lihi Eder, and Lianne Gensler; moderated by Dr. Artie Kavanaugh
Tuesday Night Rheumatology- Spondyloarthritis Spectrum
Nonradiographic Axial Spondyloarthritis - Dr. Eric Ruderman
Canary in a Coal Mine (4.19.2024)
Vasculitis Faculty Panel Q&A - featuring Drs. Catherine Sims, Anisha Dua, and Philip Seo- moderated by Dr. Jack Cush
Tuesday Night Rheumatology- Vasculitis Mavens
GPA Management in 2024 - Dr. Anisha Dua
Burnout or Retire (4.12.2024)
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive